SCHEDULE 13G: Armistice Capital and Steven Boyd Disclose 9.99% Stake in Kineta, Inc.

Armistice Capital, LLC and Steven Boyd have disclosed a 9.99% beneficial ownership stake in Kineta, Inc.'s common stock, held for investment purposes.

Summary

• Armistice Capital, LLC and Steven Boyd (collectively, the "Reporting Persons") have filed a Schedule 13G with the SEC.
• The Reporting Persons beneficially own an aggregate of 1,366,816 shares of Kineta, Inc.'s common stock.
• This ownership represents 9.99% of the total class of Kineta, Inc. common stock.
• Armistice Capital, LLC, a Delaware entity, serves as the investment manager for Armistice Capital Master Fund Ltd., which is the direct holder of the shares.
• Steven Boyd, a U.S. citizen, is the managing member of Armistice Capital, LLC.
• The shares are held with shared voting power and shared dispositive power by both Reporting Persons.
• The filing certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of Kineta, Inc.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing (Schedule 13G) disclosing beneficial ownership, which is inherently neutral in sentiment regarding the issuer's operational performance or financial health. It simply reports a factual ownership stake.

Positives

• A significant institutional investor, Armistice Capital, LLC, and its managing member, Steven Boyd, have taken a 9.99% stake in Kineta, Inc., indicating a notable investment position.
• The investment is stated to be in the ordinary course of business, suggesting a passive, long-term investment intent rather than an activist stance, which can provide stability.

Future Outlook

The document is a beneficial ownership disclosure and does not contain any forward-looking statements or guidance regarding Kineta, Inc.'s future performance or operations.

Industry Context

This Schedule 13G filing is a routine disclosure for institutional investors acquiring a significant, non-controlling stake (over 5%) in a publicly traded company. It indicates that Armistice Capital, a hedge fund, views Kineta, Inc. as a suitable investment for its portfolio, aligning with common practices of institutional asset management in the biotechnology or pharmaceutical sector where Kineta typically operates.

Stakeholder Impact

• Shareholders: The disclosure of a significant institutional investor's stake provides transparency and may influence market perception, although the filing explicitly states the investment is passive and not for control purposes.

Key Dates

Keywords

Kineta Inc., Armistice Capital, Steven Boyd, Schedule 13G, beneficial ownership, common stock, institutional investment, SEC filing, KNET